Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection.

The objectives of the new WHO Guideline on Chronic Hepatitis B aims to:

• To provide guidelines on the on the prevention, care and treatment of persons with chronic hepatitis B virus (HBV) infection – defined as persistence of hepatitis B surface antigen (HBsAg) for six months or more
• To provide a framework for the development or strengthening of hepatitis B treatment programmes in low- and middle-income countries (LMICs) that is also of relevance to some high-income countries
• To complement existing World Health Organization (WHO) guidance on the primary prevention of hepatitis B through both hepatitis B vaccination and by improving blood and injection safety, as well as guidance among persons who inject drugs (PWID) and other vulnerable groups, including those living with human immunodeficiency virus (HIV) infection 

World Health Organization (WHO). Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection. Geneva (Switzerland): World Health Organization (WHO).